Wealth Advisors Of Tampa Bay, LLC Eli Lilly & CO Transaction History

Wealth Advisors Of Tampa Bay, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Oct 25, 2018	SELL	$85.86 - $107.31 $4.29 Million - $5.36 Million	-49,965 Closed	0 $0
Q2 2018 Jul 19, 2018	SELL	$75.7 - $86.88 $15,140 - $17,376	-200 Reduced 0.4%	49,965 $4.29 Million
Q1 2018 May 11, 2018	BUY	$74.21 - $87.6 $19,888 - $23,476	268 Added 0.54%	50,165 $3.88 Million
Q4 2017 Feb 07, 2018	BUY	$81.94 - $87.89 $4.09 Million - $4.39 Million	49,897	49,897 $4.31 Million

3,725

738M

7.09M

7.24M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $869B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Wealth Advisors Of Tampa Bay, LLC, based on Form 13F filings with the SEC.

Stay updated on Wealth Advisors Of Tampa Bay, LLC with notifications on news.